E. GALLIGIONI

Development and daily use of an electronic oncological patient record for the total management of cancer patients: 7 years' experience (2009)

Galligioni, E., Berloffa, F., Caffo, O., Tonazzolli, G., Ambrosini, G., Valduga, F., ...

Background: We describe our experience with an electronic oncological patient record (EOPR) for the total management of cancer patients. Methods: The web-based EOPR was developed on the basis of a...

Gemcitabine and anthracyclines in platinum-resistant ovarian cancer (2006)

Galligioni, E., Arcuri, C., Sorio, R., Griso, C.

Background: Most of the patients with advanced ovarian cancer will recur after first-line platinum-based chemotherapy and need additional treatment. Gemcitabine (G) and Anthracyclines are active in...

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials (2005)

ABE, O, ABE, R, ENOMOTO, K, KIKUCHI, K, KOYAMA, H, MASUDA, H, ...

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials (2005)

ABE, O, ABE, R, ENOMOTO, K, KIKUCHI, K, KOYAMA, H, MASUDA, H, ...

The effect of adjuvant prednisone combined with CMF on patterns of relapse and occurrence of second malignancies in patients with breast cancer (1996)

Marini, G., Murray, S., Goldhirsch, A., Gelber, R. D., Castiglione-Gertsch, M., Price, K. N., ...

Background: The addition of low-dose prednisone (p) to the adjuvant regimen of cyclophosphamide, methotrexate, 5-fluorouracil (CMF) allowed patients to receive a larger dose of cytotoxics when...

Survival after treatment of advanced renal cell carcinoma (RCC) with high-dose interleukin-2 (rIL-2) or vinblastine (VLB) (1995)

Sorio, R., Galligioni, E., Crivellari, D., Talamini, R., Monfardini, S.

Ovarian ablation versus goserelin with or without tamoxifen in pre-perimenopausal patients with advanced breast cancer: Results of a multicentric Italian study (1994)

Boccardo, F., Rubagotti, A., Perrotta, A., Amoroso, D., Balestrero, M., De Matteis, A., ...

Background: Oophorectomy is one of the treatments of choice for premenopausal women with advanced breast cancer. However, in recent years LH-RH analogs have replaced surgical castration (or ovarian...

Original article: Natural killer (NK) and lymphokine activated killer (LAK) cell activity in patients (PTS) treated with favone acetic acid (FAA) (1991)

Galligioni, E., Quaia, M., Spada, A., Crivellari, D., Favar, D., Sorio, R., ...

Natural killer (NK) cell activity was measured in nine patients with different solid tumors treated with flavone acetic acid (FAA). In three of them, NK cell activity was significantly increased, in...

Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International Breast Cancer Study Group (IBCSG).

Bernhard, J., Hürny, C., Coates, A. S., Peterson, H. F., Castiglione-Gertsch, M., Gelber, R. D., ...

Quality of life (QL) is used to assess treatments in clinical trials but may be influenced by other factors. We analysed the impact of biomedical, sociodemographic and cultural factors on baseline QL...

Cyclosporin A as a multidrug-resistant modulator in patients with renal cell carcinoma treated with teniposide.

Toffoli, G., Sorio, R., Gigante, M., Corona, G., Galligioni, E., Boiocchi, M.

Patients with refractory metastatic renal cell carcinoma (RCC) were enrolled in a phase II study with teniposide (VM26) and cyclosporin A (CSA) to investigate (1) the effect of CSA on the response...

Multicentric phase II trial of gemcitabine plus epirubicin plus paclitaxel as first-line chemotherapy in metastatic breast cancer

Cappuzzo, F, Mazzoni, F, Gennari, A, Donati, S, Salvadori, B, Orlandini, C, ...